Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year ...

Research and development (R&D) spending by drug manufacturers flatlined in 2022, according to data released by Evaluate Vantage Friday morning. Among the world’s largest 11 drugmakers, only ...

If you want a large pharmaceutical company to invent a new drug, your best bet is probably AstraZeneca. But if you have a medicine you’d like to get to market — and you want to see it generate revenue ...

Editor's note: this interview was originally published on BioPharmInternational.com.

Pharmaceutical companies are often lambasted for rising drug costs. For example, the price of new drugs entering the US market in 2023 was 35% higher than in 2022. According to an analysis from ...

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...

In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...

"The pharmaceutical industry is embracing generative AI for several key reasons. First, the industry deals with enormous volumes of information - scientific papers, clinical trial data, regulatory ...

Last year, Pirelli showed off its first 5G-connected Cyber Tyre. This year, it's taking that connectivity a step further. Artificial intelligence (AI) helped develop Pirelli's tires of the future, its ...